FLEURY ON NM

Fleury S.A. provides medical services in various areas, including diagnostic, treatment, clinical analysis, health management, and more. The company operates through three segments: Diagnostic Medicine, Integrated Medicine, and Dental. It offers laboratory tests, imaging services, genomics, and other healthcare solutions. Fleury also has a digital healthcare platform called Saúde I for teleconsultations, test results, and electronic medical records.

Overview

Sector

Healthcare

Target Price

0.0 BRL

Current Price

24.3 BRL

Potential

65%

Strengths

With an appreciation Potential of 70.68%, based on our fundamental analysis, it suggests the stock may be undervalued.
Price to book ratio (2.56) is lower than the sector mean (9.96).
The company has high returns. ROIC (23.63%) is higher than the sector mean (7.40%).
EV/EBITDA (7.07) is lower than the sector mean (36.02).
EV/EBIT (11.39) is lower than the sector mean.
Price to free cash flow (7.87) is lower than the sector mean.
Strong EBITDA Margin of 28.70%.

Weaknesses

The company has high debt. Net Debt to EBITDA Ratio (1.68) is higher than the sector mean.

Indicator	Value
PER	100.0
EV/EBITDA	100.0
Price/Free Cash Flow'	100.0
ROIC	-%
Net Debt/EBITDA	100.0

FLEURY ON NM

Overview

Strengths

Weaknesses

Key Financial Data